Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Sacubitril or its saltsPDL I JAN / 16
Safinamide or its saltsPDL I FEB / 19
Salbutamol or its saltsPDL I DEC / 13
Salicylic acidPDL

When sold in topical formulations containing salicylic acid at concentrations greater than 20% and/or with a pH less than 3.0, except when sold to be applied to warts, corns or calluses.

I DEC / 14
Salicylic acid and its salts when sold to be applied to warts, corns or calluses in topical preparations in concentrations greater than 40% II DEC / 14
Salicylic acid and its salts.

in topical preparations in concentrations up to and including 40% (except when sold in topical formulations containing salicylic acid at concentrations greater than 20% and/or with a pH less than 3.0 for a use other than to be applied to warts, corns and calluses)

U DEC / 14
Salmeterol or its saltsPDL I DEC / 13
Salsalate or its salts or derivativesPDL I DEC / 13
Sapropterin or its saltsPDL I DEC / 13
Saquinavir or its salts or derivativesPDL I DEC / 13
Saralasin or its saltsPDL I DEC / 13
SargramostimPDL I DEC / 13
SarilumabPDL I MAR / 17
SarolanerPDL

For veterinary use.

I AUG / 16
Saxagliptin or its saltsPDL I DEC / 13
Scopolamine and its salts hyoscine, except Hyoscine butylbromide, when recommended for parenteral use II AUG / 16
Sebelipase alfaPDL I MAR / 18
SecobarbitalC1 I JUN / 02
SecukinumabPDL I MAY / 15
Selegiline or its saltsPDL I DEC / 13
Selenium in injectable form for parenteral nutrition I JAN / 03
Selexipag or its derivativesPDL I AUG / 16
SemaglutidePDL I MAR / 18
Senna and its extracts and derivatives U
Sermorelin or its saltsPDL I DEC / 13
Sertraline or its saltsPDL I DEC / 13
Sevelamer or its saltsPDL I DEC / 13
SevofluranePDL I DEC / 13
Sex hormones (natural or synthetic)PDL

For human use - including but not limited to conjugated estrogens, desogestrel, dienogest, estradiol benzoate, estradiol(hemihydrate), estrone, ethinyl estradiol, ethynodiol diacetate, etonogestrel, levonorgestrel, medroxyprogesterone acetate, norelgestromin, norethindrone acetate, norgestimate, progesterone except the following: androisoxazole, androstanolone, androstenediol or its derivatives, bolandiol or its derivatives, bolasterone, bolazine, boldenone or its derivatives, bolenol, calusterone, clostebol or its derivatives, drostanolone or its derivatives, enestebol, epitiostanol, ethylestrenol, fluoxymesterone, formebolone, furazabol, 4-Hydroxy-19-nortestosterone or its derivatives, levonorgestrel when sold as a single ingredient in an oral dosage form containing no more than 1.5 milligrams, mebolazine,mesabolone, mesterolone, metandienone, metenolone or its derivatives, methandriol, methyltestosterone or its derivatives, metribolone, mibolerone, nandrolone or its derivatives, norboletone, norclostebol or its derivatives, norethandrolone, oxabolone or its derivatives, oxandrolone, oxymesterone, oxymetholone, prasterone, quinbolone, stanozolol, stenbolone or its derivatives, testosterone or its derivatives, tibolone, tiomesterone, trenbolone or its derivatives, zeranol.

I AUG / 15
Sibutramine or its saltsPDL I DEC / 13
SigmodalC2 I JUN / 02
Sildenafil or its saltsPDL I DEC / 13
Silodosin or its salts or derivativesPDL I DEC / 13
SiltuximabPDL I DEC / 14
Silver nitrate II SEP / 98
Simeprevir or its saltsPDL I DEC / 13
SimvastatinPDL I DEC / 13
Sincalide II SEP / 98
Sirolimus or its derivativesPDL

Including but not limited to everolimus, temsirolimus.

I DEC / 13
Sitagliptin or its saltsPDL I DEC / 13
Sitaxentan or its saltsPDL I DEC / 13
Sodium acetate for parenteral use II SEP / 98
Sodium acetate in injectable form for parenteral nutrition I JAN / 03
Sodium biphosphate

for parenteral use

II SEP / 98
Sodium biphosphate.

cathartics

III SEP / 98
Sodium bromidePDL I DEC / 13
Sodium chloride single ingredient solutions for parenteral or ophthalmic use in concentrations of more than 0.9% [NOTE: Does not apply to contact lens solutions intended to be rinsed off prior to insertion into eye] II OCT / 98
Sodium chloride in injectable form for parenteral nutrition I JAN / 03
Sodium citrate for parenteral use II SEP / 98
Sodium cromoglicate (cromoglycate) in solutions in concentrations of 2% or less for ophthalmic or nasal use III SEP / 98
Sodium fluoride (see Fluoride)PDL

For human use - in solid oral dosage forms containing more than 1 mg of fluoride ion.

I DEC / 13
Sodium iodide for sclerosing II SEP / 98
Sodium iodine in injectable form for parenteral nutrition I JAN / 03
Sodium nitritePDL

When indicated for administration by injection and sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning.

I JUN / 15
Sodium nitroprusside or its saltsPDL I DEC / 13
Sodium phosphate for parenteral use II SEP / 98
Sodium phosphate in injectable form for parenteral nutrition I JAN / 03
Sodium phosphate. cathartics III SEP / 98
Sodium picosulphate

for oral purgatives, 10 mg per pack (when found in preparations with magnesium oxide 3.5 g and citric acid 12 g)

II JAN / 10
Sodium polystyrene sulfonatePDL I DEC / 13
Sodium tartrate U
Sodium tetradecylsulfate II SEP / 98
Sofosbuvir or its saltsPDL I FEB / 14
Solifenacin or its saltsPDL I DEC / 13
SomatostatinPDL I DEC / 13
SomatremPDL I DEC / 13
SomatropinPDL I DEC / 13
Sorafenib or its saltsPDL I DEC / 13
Sotalol or its saltsPDL I DEC / 13
Spectinomycin or its salts or derivativesPDL I DEC / 18
Spinosyn A and D isoformsPDL I DEC / 13
Spiramycin or its salts or derivativesPDL

For human use.

I DEC / 13
SpironolactonePDL I DEC / 13
StanozololC3 I JUN / 02
StavudinePDL I DEC / 13
StenboloneC3 I JUN / 02
StiripentolPDL I DEC / 13
Stramonium, its preparations, extracts and compounds II SEP / 98
Streptokinase as a debriding agent II SEP / 98
Streptokinase/streptodornase I SEP / 98
Streptomycin or its salts or derivativesPDL

For human use

I DEC / 18
Streptomycin or its salts or derivativesPDL

For veterinary use, including but not limited to dihydrostreptomycin

I DEC / 18
StreptozocinPDL I DEC / 13
Strontium and its salts for parenteral use II SEP / 98
Strontium bromidePDL I DEC / 13
Succinimide or its salts or derivativesPDL

Including but not limited to methsuximide, except those compounds used for decontaminating water.

I DEC / 13
Succinylcholine and its salts I SEP / 98
SucralfatePDL I SEP / 98
Sucroferric oxyhydroxidePDL I MAY / 18
SufentanilN I JUN / 02
Sugammadex or its saltsPDL I AUG / 16
Sulconazole or its saltsPDL I DEC / 13
Sulfinpyrazone or its saltsPDL I DEC / 13
Sulindac or its saltsPDL I DEC / 13
Sulphonamides or their salts or derivativesPDL

Including but not limited to Brinzolamide, succinylsulfathiazole, sulfacetamide, sulfadiazine, sulfadimethoxine, sulfadoxine, sulfaguanidine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfanilamide, sulfapyridine, sulfaquinoxaline, sulfasalazine, sulfathiazole, sulfisoxazole, sulphanilamide

I DEC / 18
Sulphones or their derivativesPDL

Including but not limited to dapsone. 

I DEC / 13
Sumatriptan or its saltsPDL I DEC / 13
Sunitinib or its saltsPDL I DEC / 13
Suprofen or its saltsPDL I DEC / 13
Sutilains II SEP / 98

103 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled